Business in the Burbs

EpiCept repays credit agreement

February

EpiCept Corp., a Tarrytown-based biotech company, said that it has repaid the outstanding principal balance and fees of a $10 million credit agreement with Hercules Technology Growth Corp., a specialty finance company in Palo Alto, Calif. EpiCept added that it has no further obligations under this agreement. EpiCept hopes to file an application seeking U.S. regulatory approval for Ceplene, a new leukemia treatment, during the second half of 2009.

This entry was posted on Tuesday, February 24th, 2009 at 6:09 pm by Jay Loomis.
You can follow any responses to this entry through the RSS 2.0 feed.
Print | Email

It is a condition of your use of the comment features associated with the blogs that you do not: Use the site to post or transmit any unlawful, threatening, abusive, libelous, defamatory, obscene, vulgar, pornographic, profane or indecent information of any kind, including without limitation any transmissions constituting or encouraging conduct that would constitute a criminal offense, give rise to civil liability or otherwise violate any local, state, national or international law. You alone are responsible for the material you post or send. Refer to the Terms of Service.